A more immunosuppressive pre-transplant conditioning may be required for Chinese patients with thalassaemia.
Matthew M. K. Shing(Chinese University of Hong Kong), Wai‐Chiu Tsoi(Chinese University of Hong Kong), K. S. Tsang(Chinese University of Hong Kong), Ki Wai Chik, Margaret H.L. Ng(Chinese University of Hong Kong), Hoang Lai, P.M.P. Yuen, Chi Kong Li(Chinese University of Hong Kong)
PubMed
June 1, 1996
Cited by 8
Related Papers
Paediatric cancer in low-income and middle-income countries
|The Lancet Oncology|2013|432
Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|JAMA Oncology|2020|245
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009
|Vox Sanguinis|2011|191